Navigation Links
DaVita Commends Kidney Care Partners for Launch of PEAK Campaign
Date:6/9/2009

Programs Designed to Address High Risks for New Dialysis Patients Making a Difference in Cutting Patient Mortality Rates

DENVER, June 9 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today commended Kidney Care Partners for launching the Performance Excellence and Accountability in Kidney Care (PEAK) campaign. Kidney Care Partners - a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with CKD - designed the project to significantly reduce the high mortality rate for patients in their first year of dialysis.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Due to complexities involved in starting dialysis - including dietary changes, vascular access management and adjusting to a regular treatment schedule, among many other factors - patients are at their most susceptible to complications during their initial transition to dialysis. PEAK is a quality improvement campaign pledging to extend, even save, as many as 10,000 lives and reduce mortality among first-year dialysis patients by 20 percent by the end of 2012.

"The kidney care community has achieved wonderful and demonstrable quality improvements in the last 10 years, and PEAK is now being launched to help us achieve the same in the next 10 years," said Kent Thiry, Chairman and Chief Executive Officer of DaVita(R). "When dialysis patients are at their most vulnerable, PEAK will work with leading researchers and experts to provide recommendations on care and education necessary to help make a difference in the lives of countless patients and their families. DaVita applauds the work of all members of Kidney Care Partners and looks forward to working together to provide even better outcomes for new dialysis patients."

As part of DaVita's commitment to continuous quality improvement, the company recently announced similar efforts with the company's IMPACT(TM) (Incident Management of Patients, Actions Centered on Treatment) pilot program. In a study presented at the National Kidney Foundation's Spring Clinical Meeting in Nashville, TN, DaVita researchers detailed how the IMPACT patient care model educates and manages dialysis patients within the first 90 days of treatment, when they are most unstable and are at highest risk. Data reflects a reduction in annualized mortality rates by eight percent for IMPACT patients compared with non-IMPACT patients in the DaVita network.

DaVita and IMPACT are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. Recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Work Places(TM), DaVita manages more than 1,475 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients - nearly one-in-three of all dialysis patients in the United States. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVitas Kidney Calculator iPhone App Downloaded in 24 Countries
2. DaVita Extends Lease to Maintain Strong Business Presence in Tacoma
3. Pamela M. Arway Joins DaVita Board of Directors
4. DaVita Announces New Corporate Headquarters in Denver, Colorado
5. DaVita Wins Eight Hermes Creative Awards Recognizing Excellence in Communications and Marketing
6. DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
7. DaVita Announces Completion of Government Investigation
8. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
9. DaVita 1st Quarter 2009 Results
10. DaVita Wins Silver in Web Health Awards
11. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in the ... Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most affordable ... the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... measurement of corrosive ions found in power plant water and steam. , Chlorides ... as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... be offered by the American Association of Integrative Medicine and available for application ... providers at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president ...
(Date:3/28/2017)... ... , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader in ... hair loss. Although hair transplant procedures can be seen as more of a man’s ... be two reasons a woman may see her hair thinning. , “We are used ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 ... to these four stocks: The Medicines Co. (NASDAQ: ... Inc. (NASDAQ: PCRX), and Supernus Pharmaceuticals Inc. (NASDAQ: ... the Generic Drugs space which is governed by ... growth drivers for the industry are wholesalers, retailers, ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... 2017 The global surgical ... value of USD 4.5 billion by 2025, according to ... closure of injured tissues post operation is a major ... occur in 3% to 15% of cases and are ... one third of postoperative deaths in patients. Surgical sealants ...
Breaking Medicine Technology: